List of articles with "BioArctic"

Leqembi Data Promises

2025-12-04 07:24:46

Sweden Stockholm Eisai Leqembi BioArctic

New Insights on Lecanemab

2025-11-19 00:19:22

Sweden Stockholm Lecanemab Eisai BioArctic

Lecanemab Insights

2025-11-19 00:08:34

Sweden Stockholm Lecanemab Eisai BioArctic

Leqembi IV Treatment

2025-11-14 00:03:21

United Kingdom Stockholm Eisai Leqembi BioArctic

BioArctic's New Ventures

2025-11-13 07:35:52

Sweden Stockholm Leqembi BioArctic Alzheimer’s treatment

BioArctic Q3 Report

2025-11-13 07:29:17

Sweden Stockholm Leqembi BioArctic Alzheimer’s Disease

Leqembi® Sales Surge

2025-10-30 10:47:51

Sweden Stockholm Eisai Leqembi BioArctic

Leqembi® Q3 Highlights

2025-10-30 10:44:19

Sweden Stockholm Eisai Leqembi BioArctic

Leqembi® Approval

2025-10-27 03:28:25

Canada Ontario Leqembi BioArctic Alzheimer’s Disease

Leqembi® Treatment Begins

2025-10-14 07:42:23

Finland Leqembi BioArctic Helsinki Alzheimer’s

Leqembi Iqlik Approved!

2025-10-14 05:28:55

Sweden Stockholm Eisai Leqembi BioArctic

Leqembi Iqlik Recognition

2025-10-14 05:17:23

Sweden Stockholm Eisai Leqembi BioArctic

Leqembi® Approval in China

2025-09-29 06:43:52

China Beijing Lecanemab Leqembi BioArctic

Leqembi® Approved

2025-09-29 06:43:29

China Beijing Leqembi BioArctic Alzheimer's

Leqembi® Approved in Australia

2025-09-24 07:12:05

Australia Leqembi BioArctic Alzheimer's Disease なし

Leqembi® Approved

2025-09-24 07:03:56

Stockholm Australia Eisai Leqembi BioArctic

Osswald Awarded Alumnus Title

2025-09-09 08:17:18

Sweden BioArctic Uppsala Gunilla Osswald Alumnus of the Year

Osswald: Alumnus of 2025

2025-09-09 08:15:07

Sweden BioArctic Uppsala Uppsala University Gunilla Osswald

BioArctic Founders Divest

2025-09-03 17:43:21

Sweden Stockholm BioArctic Lars Lannfelt Pär Gellerfors

BioArctic Founders Divest

2025-09-03 17:37:19

Sweden Stockholm Leqembi BioArctic Lars Lannfelt

Leqembi® Iqlik™ Submission

2025-09-03 03:27:19

USA Stockholm Eisai BioArctic LEQEMBI IQLIK

BioArctic Update

2025-08-28 07:01:16

Sweden Stockholm Leqembi BioArctic Novartis

BioArctic Q2 Report

2025-08-28 07:00:54

Sweden Stockholm Leqembi BioArctic Novartis

BioArctic Novartis Deal

2025-08-26 06:55:28

Sweden Stockholm BioArctic Novartis BrainTransporter

BioArctic and Novartis Deal

2025-08-26 06:55:02

Sweden Stockholm BioArctic Novartis BrainTransporter

Leqembi Launches in EU

2025-08-25 07:43:08

Sweden Stockholm Leqembi BioArctic Alzheimer's

Leqembi® Launch

2025-08-25 07:31:13

Sweden Stockholm Leqembi BioArctic Alzheimer’s

Leqembi® Sales Surge

2025-07-31 10:29:22

Sweden Stockholm Eisai Leqembi BioArctic

Leqembi® Sales Surge

2025-07-31 10:27:23

Sweden Stockholm Eisai Leqembi BioArctic

Lecanemab Update

2025-07-31 03:19:15

Sweden Stockholm Lecanemab BioArctic Alzheimer's Disease

Lecanemab AAIC 2025

2025-07-31 03:18:53

Sweden Stockholm Lecanemab Eisai BioArctic

Lecanemab Insights

2025-07-22 06:18:20

Sweden Stockholm Lecanemab Leqembi BioArctic

2025 Bioindustry Awards

2025-07-16 08:06:48

Japan BioArctic Yokohama Alzheimer's Drug Bioindustry Award

Lecanemab Wins Bioindustry Award

2025-07-16 07:58:17

Sweden Stockholm Lecanemab Eisai BioArctic

Eisai's Leqembi Awarded

2025-07-16 07:57:18

Sweden Stockholm BioArctic Award Bioindustry

Lannfelt Awarded in 2025

2025-06-26 08:43:33

Sweden Stockholm Lecanemab BioArctic Alzheimer's

Hartwig Prize Winner

2025-06-26 08:43:18

Sweden Stockholm Lecanemab BioArctic Lars Lannfelt

Exidavnemab Study Update

2025-06-13 06:52:59

Sweden Stockholm BioArctic Parkinson's exidavnemab

BioArctic Exidavnemab Update

2025-06-13 06:52:43

Sweden Stockholm Parkinson's Disease BioArctic exidavnemab

Leqembi Revenue Growth

2025-05-15 09:10:15

Sweden Stockholm Eisai Leqembi BioArctic

Eisai's Leqembi Revenue

2025-05-15 09:09:49

Sweden Stockholm Eisai Leqembi BioArctic

Exidavnemab Trial Expansion

2025-05-08 11:59:58

Sweden Stockholm BioArctic exidavnemab MSA

Exidavnemab Phase 2a Expansion

2025-05-08 11:58:34

Sweden Stockholm BioArctic exidavnemab MSA

Eisai Sales Projections

2025-03-25 07:22:20

Sweden Stockholm Lecanemab Eisai BioArctic

Eisai Sales Projection

2025-03-25 07:11:52

Sweden Stockholm Eisai Leqembi BioArctic

BioArctic Drug Designation

2025-03-17 17:57:32

Sweden Stockholm BioArctic exidavnemab MSA

Exidavnemab Designation

2025-03-17 17:56:22

Sweden Stockholm BioArctic exidavnemab MSA

Uppsala University Prize

2025-03-12 07:43:24

Sweden BioArctic Alzheimer's Uppsala Uppsala University

Honoring BioArctic's Leaders

2025-03-12 07:32:20

Sweden Innovation BioArctic Alzheimer's Uppsala

Lecanemab Not Approved

2025-03-03 08:34:13

Australia Lecanemab Eisai BioArctic Canberra